Exenatide-treated patients with elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) at baseline significantly improved at 3?years ( em P /em ? ?0
Exenatide-treated patients with elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) at baseline significantly improved at 3?years ( em P /em ? ?0.001), while patients with normal ALT and AST…